Iterum Therapeutics jumps 20% to $1.41 after FDA posts approval
PremiumThe FlyIterum Therapeutics jumps 20% to $1.41 after FDA posts approval
16d ago
Iterum Therapeutics PLC trading halted, news pending
Premium
The Fly
Iterum Therapeutics PLC trading halted, news pending
16d ago
Iterum provides update on FDA advisory committee discussion on oral sulopenem
Premium
The Fly
Iterum provides update on FDA advisory committee discussion on oral sulopenem
2M ago
Iterum announces FDA advisory committee meeting for oral sulopenem NDA
PremiumThe FlyIterum announces FDA advisory committee meeting for oral sulopenem NDA
5M ago
Iterum Therapeutics Strategizes for NASDAQ Compliance and FDA Review
Premium
Company Announcements
Iterum Therapeutics Strategizes for NASDAQ Compliance and FDA Review
5M ago
Iterum announces FDA acceptance of resubmission of oral sulopenem NDA
Premium
The Fly
Iterum announces FDA acceptance of resubmission of oral sulopenem NDA
5M ago
Iterum Therapeutics sees cash runway into 2025
PremiumThe FlyIterum Therapeutics sees cash runway into 2025
8M ago
Iterum Therapeutics reports Q4 EPS (81c) vs. (52c) last year
Premium
The Fly
Iterum Therapeutics reports Q4 EPS (81c) vs. (52c) last year
8M ago
Iterum Therapeutics expects to resubmit oral sulopenem NDA in 1H of 2Q24
Premium
The Fly
Iterum Therapeutics expects to resubmit oral sulopenem NDA in 1H of 2Q24
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100